Baron Financial Group’s Gilead Sciences GILD Stock Holding History

Baron Financial Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-300	Closed	-$18.5K	–	108
2022 Q2	$18.5K	Hold	300	–	–	0.01%	126
2022 Q1	$17.8K	Hold	300	–	–	0.01%	139
2021 Q4	$21.8K	Hold	300	–	–	0.01%	136
2021 Q3	$21K	Hold	300	–	–	0.01%	139
2021 Q2	$20.7K	Hold	300	–	–	0.01%	140
2021 Q1	$19.4K	Hold	300	–	–	0.01%	140
2020 Q4	$17.5K	Hold	300	–	–	0.01%	143
2020 Q3	$19K	Buy	+300	New	+$20.8K	0.02%	140

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Baron Financial Group's GILD Position: Q3 2022 in Review

Baron Financial Group sold out of Gilead Sciences (GILD) in Q3 2022, closing a stake of 300 shares — an estimated $18.5K sold.

Baron Financial Group first reported a position in GILD in Q3 2020 and held it in 8 quarters. The position peaked at $21.8K in Q4 2021. 1,602 funds tracked by Wall St. Rank hold GILD as of Q3 2022.

Baron Financial Group reported no remaining Gilead Sciences position as of Q3 2022 after selling out during the quarter.
Baron Financial Group sold 300 Gilead Sciences shares in Q3 2022, an estimated $18.5K.
Baron Financial Group first reported a position in Gilead Sciences in Q3 2020 and held it in 8 quarters.
Baron Financial Group's Gilead Sciences position peaked at $21.8K in Q4 2021.
1,602 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2022.

Based on Baron Financial Group's 13F filing for Q3 2022, filed 3 Nov 2022.